Technical Bulletin | Reducing the Variability of the RiboGreenĀ® Assay

Technical Bulletin | Reducing the Variability of the RiboGreen® Assay
Introduction

Ever since the approval of the Covid-19 vaccine, there has been a significant increase in interest in nucleic acid-based
medications and Lipid nanoparticles (LNPs) for targeted drug delivery. With the rapid development of such systems,
the development of quality characterization methods is trying to catch up and provide accurate and robust analysis
techniques. Meanwhile, more traditional techniques have been...

Click here for a PDF of the full technical bulletin.